What's New in Health and Life Sciences
News from the European Comission
EUROPA - Research and Innovation: Health & Life Sciences
After 117 interviews at dairy plants in 14 European countries, 53 interviews with dairy educational institutions and 65 ex-students, AEDIL is now ready to present Results & Recommendations based on the analysis of this vast amount of data.
We are very pleased to invite you to Leeuwarden, The Netherlands on the 26th of November and the 27th of November to:
- • Hear and see the results from this Erasmus+ project ‘Mapping skills needs and supply in the dairy sector’.
• Hear the recommendations we wish to give back to the dairy sector based on the analysis of data and inputs from experts.
• Give your inputs on how best to roll out the recommendations in your country and at a pan-European level.
Advances in CAR-T cell develoment made with in CARAT will be presented. Further, various aspects such as production, application and reimbursement options for this novel therapeutic approach will be examined. In addition to scientific lectures, a panel discussion on opportunities and threats of the broad application of CAR-T cell therapies from different viewpoints will be held.
Please register until November 26, 2019 by email:
Dr Martina Wessling: firstname.lastname@example.org
Tel: +49 211 385 469-9205
Venue: Representation of the State of North Rhine-Westphalia to the European Union
Rue Montoyer 47
The event will be held under the auspices of the Finnish Presidency of the EU, which will run from July to December. The Congress is in a focused format to allow concrete issues to be tackled and to have a dialogue with our policy makers. Essentially, this 3rd annual Congress will provide the ideal space to allow for a meeting of minds and expertise and represent a vital opportunity for top-level discussion and the formulation of real action plans, for example in the area of translational research.
Congress will showcase different objectives which both the public and private sector can support, with a view to allowing the EU to present a common objective. Innovation and the incentives for it are key to health and wealth in the current EU-28 (and will be even more important after the UK leaves). It also encourages investment from outside of the EU, which is good for business and jobs. It is clear that innovation needs to soar to new heights, and be implemented and integrated, for the bene t of EU citizens.